El-Ashmawy HM, et al. – Via analyzing a cohort of 270 patients with type 2 diabetes mellitus (T2DM), researchers investigated the potential of serum fetuin-B as an independent marker for nonalcoholic fatty liver disease (NAFLD). The severity of NAFLD was categorized into three subgroups by ultrasound: grade 0 (no fatty liver), grade 1 (mild fatty liver), and grade 2–3 (medium to severe fatty liver). Compared with non-NAFLD patients, those with grade 2–3 NAFLD had high fetuin-B levels. In patients with T2DM, serum fetuin-B was independently associated with NAFLD.